{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T13:41:23Z","timestamp":1792071683626,"version":"4.4.0"},"reference-count":37,"publisher":"Walter de Gruyter GmbH","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,7,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_hmbci-2019-0009_s_999_w2aab3b7b4b1b6b1aab1c14b1Aa\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Irisin, a hormone-like myokine, is suspected to have a role in metabolic syndrome (MetS) through regulating energy homeostasis and mediating physical activity. In this regard, the role of irisin and malondialdehyde (MDA) along with some other biochemical parameters in the prediction of MetS was examined in the present investigation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_hmbci-2019-0009_s_998_w2aab3b7b4b1b6b1aab1c14b2Aa\">\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>In the present case-control study, 36 subjects diagnosed with MetS according to International Diabetes Federation were considered as cases and were matched in age and gender with 31 healthy participants. The difference of biochemical indicators between cases and controls were determined whether by independent t-test or the Mann-Whitney U-test. The predictors of MetS and insulin resistance (IR) were examined through logistic and linear regressions analysis models, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_hmbci-2019-0009_s_997_w2aab3b7b4b1b6b1aab1c14b3Aa\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Irisin and MDA were not found to be predictors for MetS in logistic regression; p = 0.258 and p = 0.694, respectively. The IR was found to be the only direct predictor of MetS (p = 0.010). Similarly, in linear regression, irisin and MDA were not identified to be predictors for IR; p = 0.801 and p = 0.781, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_hmbci-2019-0009_s_996_w2aab3b7b4b1b6b1aab1c14b4Aa\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The study did not show that irisin and MDA, directly and indirectly, were predictors of MetS disorder. The IR was only predictor of MetS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/hmbci-2019-0009","type":"journal-article","created":{"date-parts":[[2019,8,4]],"date-time":"2019-08-04T09:16:26Z","timestamp":1564910186000},"source":"Crossref","is-referenced-by-count":3,"title":["Association of irisin and oxidative stress with biochemical parameters in patients with metabolic syndrome"],"prefix":"10.1515","volume":"39","author":[{"given":"Israa Issa","family":"Hassan","sequence":"first","affiliation":[{"name":"Basic Sciences Department, College of Nursing , University of Duhok , Duhok , Iraq"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan Bapeer","family":"Hassan","sequence":"additional","affiliation":[{"name":"Basic Sciences Department, College of Nursing , University of Duhok , Duhok , Iraq"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heevi Ameen","family":"Rajab","sequence":"additional","affiliation":[{"name":"Medical Chemistry Department, College of Medicine , University of Duhok , Duhok , Iraq"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farsat Saeed","family":"Saadi","sequence":"additional","affiliation":[{"name":"CPD Department , Duhok General Directorate of Health , Duhok , Iraq"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8986-5793","authenticated-orcid":false,"given":"Deldar Morad","family":"Abdulah","sequence":"additional","affiliation":[{"name":"Adult Nursing Department, College of Nursing , University of Duhok , Duhok , Iraq , Phone: +9647507443319"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayoub Abid","family":"Abdul Majeed","sequence":"additional","affiliation":[{"name":"Nursing Department, College of Nursing , University of Duhok , Duhok , Iraq"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bland Bayar","family":"Khaleel","sequence":"additional","affiliation":[{"name":"Preventive Health Directorate , Duhok , Iraq"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherzad Majeed","family":"Taher","sequence":"additional","affiliation":[{"name":"Pharmacology Department, College of Pharmacy , University of Duhok , Duhok , Iraq"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Idris Haji","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Azadi Teaching Hospital , Duhok , Iraq"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2019,8,5]]},"reference":[{"key":"2025121207160753780_j_hmbci-2019-0009_ref_001_w2aab3b7b4b1b6b1ab2b2b1Aa","doi-asserted-by":"crossref","unstructured":"Carr DB, Utzschneider KM, Hull RL, Kodama K, Retzlaff BM, Brunzell JD, et al. Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes. 2004;53:2087\u201394.","DOI":"10.2337\/diabetes.53.8.2087"},{"key":"2025121207160753780_j_hmbci-2019-0009_ref_002_w2aab3b7b4b1b6b1ab2b2b2Aa","doi-asserted-by":"crossref","unstructured":"Reaven GM. Insulin resistance: the link between obesity and cardiovascular disease. Endocrinol Metab Clin Nor Am. 2008;37:581\u2013601.","DOI":"10.1016\/j.ecl.2008.06.005"},{"key":"2025121207160753780_j_hmbci-2019-0009_ref_003_w2aab3b7b4b1b6b1ab2b2b3Aa","doi-asserted-by":"crossref","unstructured":"Bostr\u00f6m P, Wu J, Jedrychowski MP, Korde A, Ye L, Lo JC, et al. A PGC1-\u03b1-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature. 2012;481:463.","DOI":"10.1038\/nature10777"},{"key":"2025121207160753780_j_hmbci-2019-0009_ref_004_w2aab3b7b4b1b6b1ab2b2b4Aa","doi-asserted-by":"crossref","unstructured":"Polyzos SA, Kountouras J, Anastasilakis AD, Geladari EV, Mantzoros CS. Irisin in patients with nonalcoholic fatty liver disease. Metab Clin Exp. 2014;63:207\u201317.","DOI":"10.1016\/j.metabol.2013.09.013"},{"key":"2025121207160753780_j_hmbci-2019-0009_ref_005_w2aab3b7b4b1b6b1ab2b2b5Aa","doi-asserted-by":"crossref","unstructured":"Landsberg L. Insulin resistance and the metabolic syndrome. Diabetologia. 2005;48:1244\u20136.","DOI":"10.1007\/s00125-005-1818-z"},{"key":"2025121207160753780_j_hmbci-2019-0009_ref_006_w2aab3b7b4b1b6b1ab2b2b6Aa","doi-asserted-by":"crossref","unstructured":"Alberti G, Zimmet P, Shaw J, Grundy SM. The IDF consensus worldwide definition of the metabolic syndrome. Brussels: International Diabetes Federation 2006;23:469\u201380.","DOI":"10.1111\/j.1464-5491.2006.01858.x"},{"key":"2025121207160753780_j_hmbci-2019-0009_ref_007_w2aab3b7b4b1b6b1ab2b2b7Aa","doi-asserted-by":"crossref","unstructured":"Stern MP, Williams K, Gonz\u00e1lez-Villalpando C, Hunt KJ, Haffner SM. Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and\/or cardiovascular disease? Diabetes Care. 2004;27:2676\u201381.","DOI":"10.2337\/diacare.27.11.2676"},{"key":"2025121207160753780_j_hmbci-2019-0009_ref_008_w2aab3b7b4b1b6b1ab2b2b8Aa","unstructured":"Diabetes Atlas. International Diabetes Federation. Cape Town, South Africa, 2006;4."},{"key":"2025121207160753780_j_hmbci-2019-0009_ref_009_w2aab3b7b4b1b6b1ab2b2b9Aa","doi-asserted-by":"crossref","unstructured":"Pennathur S, Heinecke JW. Mechanisms for oxidative stress in diabetic cardiovascular disease. Antioxid Redox Signal. 2007;9:955\u201369.","DOI":"10.1089\/ars.2007.1595"},{"key":"2025121207160753780_j_hmbci-2019-0009_ref_010_w2aab3b7b4b1b6b1ab2b2c10Aa","doi-asserted-by":"crossref","unstructured":"Kopprasch S, Srirangan D, Bergmann S, Graessler J, Schwarz PE, Bornstein SR. Association between systemic oxidative stress and insulin resistance\/sensitivity indices \u2013 the PREDIAS study. Clin Endocrinol. 2016;84:48\u201354.","DOI":"10.1111\/cen.12811"},{"key":"2025121207160753780_j_hmbci-2019-0009_ref_011_w2aab3b7b4b1b6b1ab2b2c11Aa","doi-asserted-by":"crossref","unstructured":"Houstis N, Rosen ED, Lander ES. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature. 2006;440:944.","DOI":"10.1038\/nature04634"},{"key":"2025121207160753780_j_hmbci-2019-0009_ref_012_w2aab3b7b4b1b6b1ab2b2c12Aa","doi-asserted-by":"crossref","unstructured":"Meigs JB, Larson MG, Fox CS, Keaney JF, Vasan RS, Benjamin EJ. Association of oxidative stress, insulin resistance, and diabetes risk phenotypes: the Framingham Offspring Study. Diabetes Care. 2007;30:2529\u201335.","DOI":"10.2337\/dc07-0817"},{"key":"2025121207160753780_j_hmbci-2019-0009_ref_013_w2aab3b7b4b1b6b1ab2b2c13Aa","doi-asserted-by":"crossref","unstructured":"Matthews D, Hosker J, Rudenski A, Naylor B, Treacher D, Turner R. Homeostasis model assessment: insulin resistance and \u03b2-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412\u20139.","DOI":"10.1007\/BF00280883"},{"key":"2025121207160753780_j_hmbci-2019-0009_ref_014_w2aab3b7b4b1b6b1ab2b2c14Aa","doi-asserted-by":"crossref","unstructured":"Yoshioka T, Kawada K, Shimada T, Mori M. Lipid peroxidation in maternal and cord blood and protective mechanism against activated-oxygen toxicity in the blood. Am J Obstet Gynecol. 1979;135:372\u20136.","DOI":"10.1016\/0002-9378(79)90708-7"},{"key":"2025121207160753780_j_hmbci-2019-0009_ref_015_w2aab3b7b4b1b6b1ab2b2c15Aa","doi-asserted-by":"crossref","unstructured":"Hee Park K, Zaichenko L, Brinkoetter M, Thakkar B, Sahin-Efe A, Joung KE, et al. Circulating irisin in relation to insulin resistance and the metabolic syndrome. J Clin Endocrinol Metab. 2013;98:4899\u2013907.","DOI":"10.1210\/jc.2013-2373"},{"key":"2025121207160753780_j_hmbci-2019-0009_ref_016_w2aab3b7b4b1b6b1ab2b2c16Aa","doi-asserted-by":"crossref","unstructured":"Bostr\u00f6m PA, Fern\u00e1ndez-Real JM. Metabolism: irisin, the metabolic syndrome and follistatin in humans. Nat Rev Endocrinol. 2014;10:11.","DOI":"10.1038\/nrendo.2013.230"},{"key":"2025121207160753780_j_hmbci-2019-0009_ref_017_w2aab3b7b4b1b6b1ab2b2c17Aa","doi-asserted-by":"crossref","unstructured":"Shanaki M, Moradi N, Emamgholipour S, Fadaei R, Poustchi H. Lower circulating irisin is associated with nonalcoholic fatty liver disease and type 2 diabetes. Diabet Metab Syndr: Clin Res Rev. 2017;11:S467\u2013S72.","DOI":"10.1016\/j.dsx.2017.03.037"},{"key":"2025121207160753780_j_hmbci-2019-0009_ref_018_w2aab3b7b4b1b6b1ab2b2c18Aa","doi-asserted-by":"crossref","unstructured":"Raschke S, Elsen M, Gassenhuber H, Sommerfeld M, Schwahn U, Brockmann B, et al. Evidence against a beneficial effect of irisin in humans. PLoS One. 2013;8:e73680.","DOI":"10.1371\/journal.pone.0073680"},{"key":"2025121207160753780_j_hmbci-2019-0009_ref_019_w2aab3b7b4b1b6b1ab2b2c19Aa","doi-asserted-by":"crossref","unstructured":"Zhang Y, Li R, Meng Y, Li S, Donelan W, Zhao Y, et al. Irisin stimulates browning of white adipocytes through mitogen-activated protein kinase p38 MAP kinase and ERK MAP kinase signaling. Diabetes. 2013. DOI: 10.2337\/db13-1106.","DOI":"10.2337\/db13-1106"},{"key":"2025121207160753780_j_hmbci-2019-0009_ref_020_w2aab3b7b4b1b6b1ab2b2c20Aa","doi-asserted-by":"crossref","unstructured":"Kleiner S, Douris N, Fox EC, Mepani RJ, Verdeguer F, Wu J, et al. FGF21 regulates PGC-1\u03b1 and browning of white adipose tissues in adaptive thermogenesis. Genes Dev. 2012;26:271\u201381.","DOI":"10.1101\/gad.177857.111"},{"key":"2025121207160753780_j_hmbci-2019-0009_ref_021_w2aab3b7b4b1b6b1ab2b2c21Aa","doi-asserted-by":"crossref","unstructured":"Chen J-Q, Huang Y-Y, Gusdon AM, Qu S. Irisin: a new molecular marker and target in metabolic disorder. Lipids Health Dis. 2015;14:2.","DOI":"10.1186\/1476-511X-14-2"},{"key":"2025121207160753780_j_hmbci-2019-0009_ref_022_w2aab3b7b4b1b6b1ab2b2c22Aa","doi-asserted-by":"crossref","unstructured":"Panagiotou G, Mu L, Na B, Mukamal KJ, Mantzoros CS. Circulating irisin, omentin-1, and lipoprotein subparticles in adults at higher cardiovascular risk. Metab Clin Exp. 2014;63:1265\u201371.","DOI":"10.1016\/j.metabol.2014.06.001"},{"key":"2025121207160753780_j_hmbci-2019-0009_ref_023_w2aab3b7b4b1b6b1ab2b2c23Aa","doi-asserted-by":"crossref","unstructured":"Vaughan RA, Gannon NP, Mermier CM, Conn CA. Irisin, a unique non-inflammatory myokine in stimulating skeletal muscle metabolism. J Physiol Biochem. 2015;71:679\u201389.","DOI":"10.1007\/s13105-015-0433-9"},{"key":"2025121207160753780_j_hmbci-2019-0009_ref_024_w2aab3b7b4b1b6b1ab2b2c24Aa","doi-asserted-by":"crossref","unstructured":"Yan B, Shi X, Zhang H, Pan L, Ma Z, Liu S, et al. Association of serum irisin with metabolic syndrome in obese Chinese adults. PLoS One. 2014;9:e94235.","DOI":"10.1371\/journal.pone.0094235"},{"key":"2025121207160753780_j_hmbci-2019-0009_ref_025_w2aab3b7b4b1b6b1ab2b2c25Aa","doi-asserted-by":"crossref","unstructured":"Jedrychowski MP, Wrann CD, Paulo JA, Gerber KK, Szpyt J, Robinson MM, et al. Detection and quantitation of circulating human irisin by tandem mass spectrometry. Cell Metab. 2015;22:734\u201340.","DOI":"10.1016\/j.cmet.2015.08.001"},{"key":"2025121207160753780_j_hmbci-2019-0009_ref_026_w2aab3b7b4b1b6b1ab2b2c26Aa","doi-asserted-by":"crossref","unstructured":"McMillan AC, White MD. Induction of thermogenesis in brown and beige adipose tissues: molecular markers, mild cold exposure and novel therapies. Curr Opin Endocrinol Diabet Obes. 2015;22:347\u201352.","DOI":"10.1097\/MED.0000000000000191"},{"key":"2025121207160753780_j_hmbci-2019-0009_ref_027_w2aab3b7b4b1b6b1ab2b2c27Aa","doi-asserted-by":"crossref","unstructured":"Sesti G, Andreozzi F, Fiorentino T, Mannino G, Sciacqua A, Marini M, et al. High circulating irisin levels are associated with insulin resistance and vascular atherosclerosis in a cohort of nondiabetic adult subjects. Acta Diabetol. 2014;51:705\u201313.","DOI":"10.1007\/s00592-014-0576-0"},{"key":"2025121207160753780_j_hmbci-2019-0009_ref_028_w2aab3b7b4b1b6b1ab2b2c28Aa","doi-asserted-by":"crossref","unstructured":"Crujeiras AB, Zulet MA, Lopez-Legarrea P, de la Iglesia R, Pardo M, Carreira MC, et al. Association between circulating irisin levels and the promotion of insulin resistance during the weight maintenance period after a dietary weight-lowering program in obese patients. Metab Clin Exp. 2014;63:520\u201331.","DOI":"10.1016\/j.metabol.2013.12.007"},{"key":"2025121207160753780_j_hmbci-2019-0009_ref_029_w2aab3b7b4b1b6b1ab2b2c29Aa","doi-asserted-by":"crossref","unstructured":"Huh JY, Panagiotou G, Mougios V, Brinkoetter M, Vamvini MT, Schneider BE, et al. FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise. Metab Clin Exp. 2012;61:1725\u201338.","DOI":"10.1016\/j.metabol.2012.09.002"},{"key":"2025121207160753780_j_hmbci-2019-0009_ref_030_w2aab3b7b4b1b6b1ab2b2c30Aa","doi-asserted-by":"crossref","unstructured":"Crujeiras AB, Pardo M, Arturo RR, Santiago NC, Zulet MA, Mart\u00ednez JA, et al. Longitudinal variation of circulating irisin after an energy restriction \u2013 induced weight loss and following weight regain in obese men and women. Am J Hum Biol. 2014;26:198\u2013207.","DOI":"10.1002\/ajhb.22493"},{"key":"2025121207160753780_j_hmbci-2019-0009_ref_031_w2aab3b7b4b1b6b1ab2b2c31Aa","doi-asserted-by":"crossref","unstructured":"Pardo M, Crujeiras AB, Amil M, Aguera Z, Jim\u00e9nez-Murcia S, Ba\u00f1os R, et al. Association of irisin with fat mass, resting energy expenditure, and daily activity in conditions of extreme body mass index. Int J Endocrinol. 2014;2014.","DOI":"10.1155\/2014\/857270"},{"key":"2025121207160753780_j_hmbci-2019-0009_ref_032_w2aab3b7b4b1b6b1ab2b2c32Aa","doi-asserted-by":"crossref","unstructured":"Crujeiras A, Pardo M, Casanueva F. Irisin:\u2018fat\u2019or artefact. Clin Endocrinol. 2015;82:467\u201374.","DOI":"10.1111\/cen.12627"},{"key":"2025121207160753780_j_hmbci-2019-0009_ref_033_w2aab3b7b4b1b6b1ab2b2c33Aa","doi-asserted-by":"crossref","unstructured":"Taszarek A, Kaczmarkiewicz A, Miazgowski T. Hypertension and beyond \u2013 does circulating irisin matter? Arterial Hypertens. 2016;20:16\u201320.","DOI":"10.5603\/AH.2016.0004"},{"key":"2025121207160753780_j_hmbci-2019-0009_ref_034_w2aab3b7b4b1b6b1ab2b2c34Aa","doi-asserted-by":"crossref","unstructured":"Assyov Y, Gateva A, Tsakova A, Kamenov Z. Irisin in the glucose continuum. Exp Clin Endocrinol Diabet. 2016;124:22\u20137.","DOI":"10.1055\/s-0035-1564130"},{"key":"2025121207160753780_j_hmbci-2019-0009_ref_035_w2aab3b7b4b1b6b1ab2b2c35Aa","doi-asserted-by":"crossref","unstructured":"Qiu S, Cai X, Yin H, Z\u00fcgel M, Sun Z, Steinacker JM, et al. Association between circulating irisin and insulin resistance in non-diabetic adults: a meta-analysis. Metab Clin Experiment. 2016;65:825\u201334.","DOI":"10.1016\/j.metabol.2016.02.006"},{"key":"2025121207160753780_j_hmbci-2019-0009_ref_036_w2aab3b7b4b1b6b1ab2b2c36Aa","doi-asserted-by":"crossref","unstructured":"Delvarianzadeh M, Abbasian M, Khosravi F, Ebrahimi H, Ebrahimi MH, Fazli M. Appropriate anthropometric indices of obesity and overweight for diagnosis of metabolic syndrome and its relationship with oxidative stress. Diabet Metab Syndr: Clin Res Rev. 2017;11:S907\u201311.","DOI":"10.1016\/j.dsx.2017.07.014"},{"key":"2025121207160753780_j_hmbci-2019-0009_ref_037_w2aab3b7b4b1b6b1ab2b2c37Aa","doi-asserted-by":"crossref","unstructured":"Abbasian M, Delvarianzadeh M, Ebrahimi H, Khosravi F, Nourozi P. Relationship between serum levels of oxidative stress and metabolic syndrome components. Diabet Metab Syndr: Clin Res Rev. 2018;12:497\u2013500.","DOI":"10.1016\/j.dsx.2018.03.015"}],"container-title":["Hormone Molecular Biology and Clinical Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.degruyter.com\/view\/j\/hmbci.2019.39.issue-1\/hmbci-2019-0009\/hmbci-2019-0009.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/hmbci-2019-0009\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/hmbci-2019-0009\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T08:06:42Z","timestamp":1765526802000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/hmbci-2019-0009\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,1]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,8,9]]},"published-print":{"date-parts":[[2019,7,26]]}},"alternative-id":["10.1515\/hmbci-2019-0009"],"URL":"https:\/\/doi.org\/10.1515\/hmbci-2019-0009","relation":{},"ISSN":["1868-1891","1868-1883"],"issn-type":[{"value":"1868-1891","type":"electronic"},{"value":"1868-1883","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7,1]]},"article-number":"20190009"}}